Deals were a key driver in Asia-Pacific, where companies formed partnerships to position themselves in an environment characterized by brisk growth, increasing competition, and sweeping regulatory changes. There was unprecedented consolidation among Japan's largest pharmaceutical companies, as well as noteworthy deals across the region. - Donn Szaro Quotes
Deals were a key driver in Asia-Pacific, where companies formed partnerships to position themselves in an environment characterized by brisk growth, increasing competition, and sweeping regulatory changes. There was unprecedented consolidation among Japan's largest pharmaceutical companies, as well as noteworthy deals across the region. Donn Szaro
 

More - Donn Szaro Quotes

Deals were a key driver in Asia-Pacific, where companies formed partnerships to position themselves in an environment characterized by brisk growth, increasing competition, and sweeping regulatory changes. There was unprecedented consolidation among Japan's largest pharmaceutical companies, as well as noteworthy deals across the region. - Donn Szaro Quotes

Deals were a key driver in Asia-Pacific, where companies formed partnerships to position themselves in an environment characterized by brisk growth, increasing competition, and sweeping regulatory changes. There was unprecedented consolidation among Japan's largest pharmaceutical companies, as well as noteworthy deals across the region.

Donn Szaro

 
Since our first report 20 years ago, we've seen historic scientific advances and dramatic changes in market conditions combine to produce a rapidly maturing industry. Companies from around the globe are pioneering new technologies, platforms, industry segments, and business models. - Donn Szaro Quotes

Since our first report 20 years ago, we've seen historic scientific advances and dramatic changes in market conditions combine to produce a rapidly maturing industry. Companies from around the globe are pioneering new technologies, platforms, industry segments, and business models.

Donn Szaro

 
We believe even more so that at least the U.S. public [biotech] sector will be profitable before the end of this decade. - Donn Szaro Quotes

We believe even more so that at least the U.S. public [biotech] sector will be profitable before the end of this decade.

Donn Szaro

 
The global biotechnology industry's revenues are growing at strong rates, product approvals are bringing innovative drugs to market, and the long- elusive goal of profitability is quickly approaching. - Donn Szaro Quotes

The global biotechnology industry's revenues are growing at strong rates, product approvals are bringing innovative drugs to market, and the long- elusive goal of profitability is quickly approaching.

Donn Szaro

 Profitability
Dyadic International wouldn't have made the list the year before but did in 2005 after changing its focus. - Donn Szaro Quotes

Dyadic International wouldn't have made the list the year before but did in 2005 after changing its focus.

Donn Szaro

 
Click To See More Quotes

Quotes By Popular Topics
Best Friends
Birthday
Change
Education
Family
Friends
Funny
Happiness
Hard Work
inspirational
Leadership
Life
Lifestyle
Lost Love
Love
Motivational
Positive
Smile
Smiles
Success
Work
View All Topics (A - Z)
Like Our Facebook Page
Motivational, Inspirational, Funny Quotes